AcuFocus
AqueSys
Cellutions
Cerebral Vascular Applications
Halscion  
LipoSonix
NeoVista
Neuronetics
NovaLign
Sebacia




Halscion

Date Founded
2008

Innovation
Halscion is developing a novel and proprietary hydrogel scaffold, Celotres(tm), to prevent or minimize scar formation, including keloid and hypertrophic scars.

Funding
Halscion has raised $14 million in Series B financing.

Contact
1325 Satellite Blvd, Suite 1004
Suwanee, GA 30024
678.534.5950 phone
678.666.1340 fax

www.halscion.net
info@halscion.net

 



Overview : Portfolio : Funding : Join Our Team : Contact Us